IPO Boutique Research, Color & More Information for Subscribers
This content is restricted to IPO Boutique Subscribers Username or Email Password Remember me Lost your password? Become a Subscriber Disclaimer IPO Boutique aggregates information on public companies and private companies, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry[…]
This content is restricted to IPO Boutique Subscribers Username or Email Password Remember me Lost your password? Become a Subscriber Disclaimer IPO Boutique aggregates information on public companies and private companies, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry[…]
This content is restricted to IPO Boutique Subscribers Username or Email Password Remember me Lost your password? Become a Subscriber Disclaimer IPO Boutique aggregates information on public companies and private companies, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry[…]
IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis. If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Aclaris Therapeutics, Inc. Symbol: ACRS Price: Last trade $22.86 Trade Date: 11/18 Shares: 2.8 million Underwriter(s)Jefferies, Leerink Partners, Guggenheim Securities CoManager(s)William[…]
The IPO market showed signs of life with 18 deals coming to market. However, slightly less than half of these deals were healthcare related (8 of 18) and many of the deals in October saw the buy-side firmly in control as 13 of the deals were priced below their initial intended ranges, respectively. In October[…]
This past week five IPOs debuted, three updated terms and seven new deals were filed. Of the five deals that debuted this week, four needed to price significantly below their initial ranges in order to come to market. The single deal that was priced in-range, Pure Storage (NYSE: PSTG), opened $0.26 below its $17.00 IPO price[…]
Become a subscriber of IPOBoutique to obtain ratings and get real-time color of new IPOs building up to each of the companies debuts. There are one-time, monthly and annual plans available. Wednesday, October 7 Aclaris Therapeutics (Nasdaq: ACRS) Pure Storage, Inc. (NYSE: PSTG) Thursday, October 8 CytomX Therapeutics (Nasdaq: CTMX) Allegiance Bancshares (Nasdaq: ABTX) CPI[…]